Literature DB >> 11491307

One novel and two recurrent missense DKC1 mutations in patients with dyskeratosis congenita (DKC).

N S Heiss1, A Mégarbané, S M Klauck, F R Kreuz, E Makhoul, F Majewski, A Poustka.   

Abstract

X-linked dyskeratosis congenita (DKC) is a progressive multisystem disorder most severely affecting tissues with a high cellular turnover such as skin, mucous membranes, and blood. Most patients die of bone marrow failure, although the chances of succumbing to various types of cancer and pulmonary disease are also high. DKC is caused predominantly by missense mutations in the DKC1 gene linked to Xq28. Some of the clinical features are reminiscent of premature ageing and this agrees with recent indications that DKC could be a telomere maintenance disorder. There is considerable variability in the type, severity, and age at onset of the various anomalies. Recognition of this has increased with the finding that patients with Hoyeraal-Hreidarsson syndrome (HHS) who exhibit severe neurological problems in addition to early-onset pancytopenia, also bear mutations in the DKC1 gene. For these reasons, and compounded by the range of mutations, phenotype-genotype correlations and accurate assessments of prognosis have not been possible. To complement the present data, we here report on three new cases of DKC and their mutations. One is a novel mutation in the exon 3 (K43E). The other two represent a frequently recurring mutation in exon 11 (A353V) and a less frequently recurring mutation in the exon 3 (T49M).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11491307

Source DB:  PubMed          Journal:  Genet Couns        ISSN: 1015-8146


  8 in total

1.  Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling.

Authors:  Hinh Ly
Journal:  World J Stem Cells       Date:  2011-10-26       Impact factor: 5.326

Review 2.  It all comes together at the ends: telomerase structure, function, and biogenesis.

Authors:  Joshua D Podlevsky; Julian J-L Chen
Journal:  Mutat Res       Date:  2011-11-07       Impact factor: 2.433

Review 3.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

4.  Telomere dysfunction in human diseases: the long and short of it!

Authors:  Kathryn A Carroll; Hinh Ly
Journal:  Int J Clin Exp Pathol       Date:  2009-05-10

Review 5.  Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome).

Authors:  Yves Sznajer; Clarisse Baumann; Albert David; Hubert Journel; Didier Lacombe; Yves Perel; Pascale Blouin; Jean-François Segura; Jean-Pierre Cezard; Michel Peuchmaur; Tomy Vulliamy; Inderjeet Dokal; Alain Verloes
Journal:  Eur J Pediatr       Date:  2003-09-30       Impact factor: 3.183

6.  Telomerase dysfunction and dyskeratosis congenita.

Authors:  Amanda J Walne; Inderjeet Dokal
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

7.  N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation.

Authors:  Deanna E MacNeil; Patrick Lambert-Lanteigne; Chantal Autexier
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

8.  Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad.

Authors:  Liqing Wang; Jianwei Li; Qiuhong Xiong; Yong-An Zhou; Ping Li; Changxin Wu
Journal:  Front Pediatr       Date:  2022-04-06       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.